In the present study, we report a GSCs-mediated angiogenesis manner, in which IFITM3 expressed in GSCs regulates JAK/STAT3 signaling pathway that preferentially stimulates bFGF production, leading to tumor angiogenesis. The gene discussed is FGF2; the disease is neoplasm.